Subunit selective decrease of AMPA and metabotropic glutamate receptor mRNA expression in rat brain by systemic administration of the NMDA receptor blocker MK-801

Journal of Molecular Neuroscience

Volumn 21, Issue 1, 2003, Pages 29-34

  Storvik, Markus ^a   Lindén, Anni Maija ^a   Lakso, Merja ^a   Wong, Garry ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

AMPA; Excitatory; Glutamate receptor; Metabotropic

Indexed keywords

AMPA RECEPTOR; DIZOCILPINE; METABOTROPIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; IN SITU HYBRIDIZATION; MALE; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING;

ANIMALS; BRAIN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MALE; PROTEIN SUBUNITS; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; SYNAPTIC TRANSMISSION;

ANIMALIA; MAMMALIA;

EID: 0141562028     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:21:1:29     Document Type: Article

References (29)

1. Cartmell J., Monn J. A., and Schoepp D. D. (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J. Pharmacol. Exp. Ther. 291(1), 161-170.
2. Cartmell J., Monn J. A., and Schoepp D. D. (2000) The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. Eur. J. Pharmacol. 400(2,3), 221-224.
3. Conn P. J. and Pin J. P. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205-237.
4. Dingledine R., Borges K., Bowie D., and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
5. Fletcher E. J. and Lodge D. (1996) New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacol. Ther. 70, 65-89.
6. Helmuth L. (2002) New therapies. New Alzheimer's treatments that may ease the mind. Science 297, 1260-1262.
7. Huettner J. E. and Bean B. P. (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci, 85, 1307-1311.
8. Hyytiä, P., Backström P., and Liljequist S. (1999) Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur. J. Pharmacol. 378, 9-16.
9. Krystal J. H., D'Souza D. C., Petrakis I. L., Belger A., Berman R. M., Charney D. S., et al. (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv. Rev. Psychiatry 7(3), 125-143.
10. Lindén A. M., Väisänen J., Wong G., and Castren E. (1997) NMDA receptor 2C subunit is selectively decreased by MK-801 in the entorhinal cortex. Eur. J. Pharmacol. 319, R1-2.
11. Lindén A. M., Storvik M., Lakso M., Haapasalo A., Lee D., Witkin J. M., et al. (2001a) Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801. Neuropharmacology 40, 469-481.
12. Lindén A. M., Väisänen J., Storvik M., Lakso M., Korpi E. R., Wong G., and Castren E. (2001b) Uncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex. Pharmacol. Toxicol. 88, 98-105.
13. Messenger M. J., Dawson L. G., and Duty S. (2002) Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology 43, 261-271.
14. Minoshima T. and Nakanishi S. (1999) Structural organization of the mouse metabotropic glutamate receptor subtype 3 gene and its regulation by growth factors in cultured cortical astrocytes. J. Biochem. (Tokyo) 126, 889-896.
15. Palmer G. C. (2001) Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr. Drug Targets 2, 241-271.
16. Parsons C. G. (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur. J. Pharmacol. 429, 71-78.
17. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Second Edition. Academic Press, New York, USA.
18. Sato K., Kiyama H., and Tohyama M. (1993) The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52(3), 515-539.
19. Schoepp D. D. (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299, 12-20.
20. Schoepp D. D., Jane D. E., and Monn J. A. (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38, 1431-1476.
21. Sheng M., Thompson M. A., and Greenberg M. E. (1991) CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427-1430.
22. Skolnick P. (1999) Antidepressants for the new millennium. Eur. J. Pharmacol. 375, 31-40.
23. Storvik M., Lindén A. M., Kontkanen O., Lakso M., Castrén E., and Wong G. (2000) Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D-aspartate receptor antagonists. J. Pharmacol. Exp. Ther. 294, 52-60.
24. Testa C. M., Standaert D. G., Young A. B., and Penney J. B., Jr. (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14(5 Pt 2), 3005-3018.
25. Törönen P., Storvik M., Lindén A. M., Kontkanen O., Marvanová M., Lakso M., et al. (2002) Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain. Neurochem. Res. 27, 1205-1216.
26. Toyooka K., Usui M., Washiyama K., Kumanishi T., and Takahashi Y. (2002) Gene expression profiles in the brain from phencyclidine-treated mouse by using DNA microarray. Ann. N. Y. Acad. Sci. 965, 10-20.
27. Tricklebank M. D., Singh L., Oles R. J., Preston C., and Iverson S. D. (1989) The behavioral effects of MK-801: a comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127-135.
28. Verdoorn T. A., Burnashev N., Monyer H., Seeburg P. H., and Sakmann B. (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715-1718.
29. Wisden W. and Morris B. (1994) In Situ Hybridization with Synthetic Oligonucleotide Probes. Academic Press, London, UK.